Could a malaria drug help fight resistant colon cancer?

This study tests whether adding hydroxychloroquine (a drug used for malaria) to standard targeted therapy can help shrink tumors in people with advanced colorectal cancer that has a specific BRAF mutation and has stopped responding to prior treatments. The trial enrolled 7 adults with stage IV disease. The goal is to see if blocking a process called autophagy can overcome treatment resistance.